Pertussis Vaccine Market - Global Outlook and Forecast 2021-2027

Pertussis Vaccine Market - Global Outlook and Forecast 2021-2027

Category

Pharmaceuticals

Published Date

5th Mar 2021

Pages

91

Choose License

Final Price

This report contains market size and forecasts of Pertussis Vaccine in global, including the following market information:
Global Pertussis Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Pertussis Vaccine Market Sales, 2016-2021, 2022-2027, (K Doses)
Global top five Pertussis Vaccine companies in 2020 (%)
The global Pertussis Vaccine market was valued at 5131.7 million in 2020 and is projected to reach US$ 5432.7 million by 2027, at a CAGR of 1.4% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pertussis Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pertussis Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Doses)
Global Pertussis Vaccine Market Segment Percentages, By Type, 2020 (%)
Whole-cell vaccines
Acellular vaccines

Global Pertussis Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Doses)
Global Pertussis Vaccine Market Segment Percentages, By Application, 2020 (%)
Children
Adults

Global Pertussis Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Doses)
Global Pertussis Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pertussis Vaccine revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Pertussis Vaccine revenues share in global market, 2020 (%)
Key companies Pertussis Vaccine sales in global market, 2016-2021 (Estimated), (K Doses)
Key companies Pertussis Vaccine sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
1 Introduction to Research & Analysis Reports
1.1 Pertussis Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pertussis Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pertussis Vaccine Overall Market Size
2.1 Global Pertussis Vaccine Market Size: 2021 VS 2027
2.2 Global Pertussis Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Pertussis Vaccine Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Pertussis Vaccine Players in Global Market
3.2 Top Global Pertussis Vaccine Companies Ranked by Revenue
3.3 Global Pertussis Vaccine Revenue by Companies
3.4 Global Pertussis Vaccine Sales by Companies
3.5 Global Pertussis Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Pertussis Vaccine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Pertussis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pertussis Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Pertussis Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Pertussis Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pertussis Vaccine Market Size Markets, 2021 & 2027
4.1.2 Whole-cell vaccines
4.1.3 Acellular vaccines
4.2 By Type - Global Pertussis Vaccine Revenue & Forecasts
4.2.1 By Type - Global Pertussis Vaccine Revenue, 2016-2021
4.2.2 By Type - Global Pertussis Vaccine Revenue, 2022-2027
4.2.3 By Type - Global Pertussis Vaccine Revenue Market Share, 2016-2027
4.3 By Type - Global Pertussis Vaccine Sales & Forecasts
4.3.1 By Type - Global Pertussis Vaccine Sales, 2016-2021
4.3.2 By Type - Global Pertussis Vaccine Sales, 2022-2027
4.3.3 By Type - Global Pertussis Vaccine Sales Market Share, 2016-2027
4.4 By Type - Global Pertussis Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pertussis Vaccine Market Size, 2021 & 2027
5.1.2 Children
5.1.3 Adults
5.2 By Application - Global Pertussis Vaccine Revenue & Forecasts
5.2.1 By Application - Global Pertussis Vaccine Revenue, 2016-2021
5.2.2 By Application - Global Pertussis Vaccine Revenue, 2022-2027
5.2.3 By Application - Global Pertussis Vaccine Revenue Market Share, 2016-2027
5.3 By Application - Global Pertussis Vaccine Sales & Forecasts
5.3.1 By Application - Global Pertussis Vaccine Sales, 2016-2021
5.3.2 By Application - Global Pertussis Vaccine Sales, 2022-2027
5.3.3 By Application - Global Pertussis Vaccine Sales Market Share, 2016-2027
5.4 By Application - Global Pertussis Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Pertussis Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Pertussis Vaccine Revenue & Forecasts
6.2.1 By Region - Global Pertussis Vaccine Revenue, 2016-2021
6.2.2 By Region - Global Pertussis Vaccine Revenue, 2022-2027
6.2.3 By Region - Global Pertussis Vaccine Revenue Market Share, 2016-2027
6.3 By Region - Global Pertussis Vaccine Sales & Forecasts
6.3.1 By Region - Global Pertussis Vaccine Sales, 2016-2021
6.3.2 By Region - Global Pertussis Vaccine Sales, 2022-2027
6.3.3 By Region - Global Pertussis Vaccine Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Pertussis Vaccine Revenue, 2016-2027
6.4.2 By Country - North America Pertussis Vaccine Sales, 2016-2027
6.4.3 US Pertussis Vaccine Market Size, 2016-2027
6.4.4 Canada Pertussis Vaccine Market Size, 2016-2027
6.4.5 Mexico Pertussis Vaccine Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Pertussis Vaccine Revenue, 2016-2027
6.5.2 By Country - Europe Pertussis Vaccine Sales, 2016-2027
6.5.3 Germany Pertussis Vaccine Market Size, 2016-2027
6.5.4 France Pertussis Vaccine Market Size, 2016-2027
6.5.5 U.K. Pertussis Vaccine Market Size, 2016-2027
6.5.6 Italy Pertussis Vaccine Market Size, 2016-2027
6.5.7 Russia Pertussis Vaccine Market Size, 2016-2027
6.5.8 Nordic Countries Pertussis Vaccine Market Size, 2016-2027
6.5.9 Benelux Pertussis Vaccine Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Pertussis Vaccine Revenue, 2016-2027
6.6.2 By Region - Asia Pertussis Vaccine Sales, 2016-2027
6.6.3 China Pertussis Vaccine Market Size, 2016-2027
6.6.4 Japan Pertussis Vaccine Market Size, 2016-2027
6.6.5 South Korea Pertussis Vaccine Market Size, 2016-2027
6.6.6 Southeast Asia Pertussis Vaccine Market Size, 2016-2027
6.6.7 India Pertussis Vaccine Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Pertussis Vaccine Revenue, 2016-2027
6.7.2 By Country - South America Pertussis Vaccine Sales, 2016-2027
6.7.3 Brazil Pertussis Vaccine Market Size, 2016-2027
6.7.4 Argentina Pertussis Vaccine Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pertussis Vaccine Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Pertussis Vaccine Sales, 2016-2027
6.8.3 Turkey Pertussis Vaccine Market Size, 2016-2027
6.8.4 Israel Pertussis Vaccine Market Size, 2016-2027
6.8.5 Saudi Arabia Pertussis Vaccine Market Size, 2016-2027
6.8.6 UAE Pertussis Vaccine Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Corporate Summary
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur Pertussis Vaccine Major Product Offerings
7.1.4 Sanofi Pasteur Pertussis Vaccine Sales and Revenue in Global (2016-2021)
7.1.5 Sanofi Pasteur Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Pertussis Vaccine Major Product Offerings
7.2.4 GSK Pertussis Vaccine Sales and Revenue in Global (2016-2021)
7.2.5 GSK Key News
7.3 Mitsubishi Tanabe Pharma
7.3.1 Mitsubishi Tanabe Pharma Corporate Summary
7.3.2 Mitsubishi Tanabe Pharma Business Overview
7.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Major Product Offerings
7.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales and Revenue in Global (2016-2021)
7.3.5 Mitsubishi Tanabe Pharma Key News
7.4 Wuhan Institute of Biological Products
7.4.1 Wuhan Institute of Biological Products Corporate Summary
7.4.2 Wuhan Institute of Biological Products Business Overview
7.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Major Product Offerings
7.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Sales and Revenue in Global (2016-2021)
7.4.5 Wuhan Institute of Biological Products Key News
7.5 Walvax Biotechnology
7.5.1 Walvax Biotechnology Corporate Summary
7.5.2 Walvax Biotechnology Business Overview
7.5.3 Walvax Biotechnology Pertussis Vaccine Major Product Offerings
7.5.4 Walvax Biotechnology Pertussis Vaccine Sales and Revenue in Global (2016-2021)
7.5.5 Walvax Biotechnology Key News
7.6 Minhai Biotechnology
7.6.1 Minhai Biotechnology Corporate Summary
7.6.2 Minhai Biotechnology Business Overview
7.6.3 Minhai Biotechnology Pertussis Vaccine Major Product Offerings
7.6.4 Minhai Biotechnology Pertussis Vaccine Sales and Revenue in Global (2016-2021)
7.6.5 Minhai Biotechnology Key News
8 Global Pertussis Vaccine Production Capacity, Analysis
8.1 Global Pertussis Vaccine Production Capacity, 2016-2027
8.2 Pertussis Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pertussis Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pertussis Vaccine Supply Chain Analysis
10.1 Pertussis Vaccine Industry Value Chain
10.2 Pertussis Vaccine Upstream Market
10.3 Pertussis Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pertussis Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables_x000D_
Table 1. Key Players of Pertussis Vaccine in Global Market_x000D_
Table 2. Top Pertussis Vaccine Players in Global Market, Ranking by Revenue (2019)_x000D_
Table 3. Global Pertussis Vaccine Revenue by Companies, (US$, Mn), 2016-2021_x000D_
Table 4. Global Pertussis Vaccine Revenue Share by Companies, 2016-2021_x000D_
Table 5. Global Pertussis Vaccine Sales by Companies, (K Doses), 2016-2021_x000D_
Table 6. Global Pertussis Vaccine Sales Share by Companies, 2016-2021_x000D_
Table 7. Key Manufacturers Pertussis Vaccine Price (2016-2021) & (USD/Doses)_x000D_
Table 8. Global Manufacturers Pertussis Vaccine Product Type_x000D_
Table 9. List of Global Tier 1 Pertussis Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share_x000D_
Table 10. List of Global Tier 2 and Tier 3 Pertussis Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share_x000D_
Table 11. By Type – Global Pertussis Vaccine Revenue, (US$, Mn), 2021 VS 2027_x000D_
Table 12. By Type - Global Pertussis Vaccine Revenue (US$, Mn), 2016-2021_x000D_
Table 13. By Type - Global Pertussis Vaccine Revenue (US$, Mn), 2022-2027_x000D_
Table 14. By Type - Global Pertussis Vaccine Sales (K Doses), 2016-2021_x000D_
Table 15. By Type - Global Pertussis Vaccine Sales (K Doses), 2022-2027_x000D_
Table 16. By Application – Global Pertussis Vaccine Revenue, (US$, Mn), 2021 VS 2027_x000D_
Table 17. By Application - Global Pertussis Vaccine Revenue (US$, Mn), 2016-2021_x000D_
Table 18. By Application - Global Pertussis Vaccine Revenue (US$, Mn), 2022-2027_x000D_
Table 19. By Application - Global Pertussis Vaccine Sales (K Doses), 2016-2021_x000D_
Table 20. By Application - Global Pertussis Vaccine Sales (K Doses), 2022-2027_x000D_
Table 21. By Region – Global Pertussis Vaccine Revenue, (US$, Mn), 2021 VS 2027_x000D_
Table 22. By Region - Global Pertussis Vaccine Revenue (US$, Mn), 2016-2021_x000D_
Table 23. By Region - Global Pertussis Vaccine Revenue (US$, Mn), 2022-2027_x000D_
Table 24. By Region - Global Pertussis Vaccine Sales (K Doses), 2016-2021_x000D_
Table 25. By Region - Global Pertussis Vaccine Sales (K Doses), 2022-2027_x000D_
Table 26. By Country - North America Pertussis Vaccine Revenue, (US$, Mn), 2016-2021_x000D_
Table 27. By Country - North America Pertussis Vaccine Revenue, (US$, Mn), 2022-2027_x000D_
Table 28. By Country - North America Pertussis Vaccine Sales, (K Doses), 2016-2021_x000D_
Table 29. By Country - North America Pertussis Vaccine Sales, (K Doses), 2022-2027_x000D_
Table 30. By Country - Europe Pertussis Vaccine Revenue, (US$, Mn), 2016-2021_x000D_
Table 31. By Country - Europe Pertussis Vaccine Revenue, (US$, Mn), 2022-2027_x000D_
Table 32. By Country - Europe Pertussis Vaccine Sales, (K Doses), 2016-2021_x000D_
Table 33. By Country - Europe Pertussis Vaccine Sales, (K Doses), 2022-2027_x000D_
Table 34. By Region - Asia Pertussis Vaccine Revenue, (US$, Mn), 2016-2021_x000D_
Table 35. By Region - Asia Pertussis Vaccine Revenue, (US$, Mn), 2022-2027_x000D_
Table 36. By Region - Asia Pertussis Vaccine Sales, (K Doses), 2016-2021_x000D_
Table 37. By Region - Asia Pertussis Vaccine Sales, (K Doses), 2022-2027_x000D_
Table 38. By Country - South America Pertussis Vaccine Revenue, (US$, Mn), 2016-2021_x000D_
Table 39. By Country - South America Pertussis Vaccine Revenue, (US$, Mn), 2022-2027_x000D_
Table 40. By Country - South America Pertussis Vaccine Sales, (K Doses), 2016-2021_x000D_
Table 41. By Country - South America Pertussis Vaccine Sales, (K Doses), 2022-2027_x000D_
Table 42. By Country - Middle East & Africa Pertussis Vaccine Revenue, (US$, Mn), 2016-2021_x000D_
Table 43. By Country - Middle East & Africa Pertussis Vaccine Revenue, (US$, Mn), 2022-2027_x000D_
Table 44. By Country - Middle East & Africa Pertussis Vaccine Sales, (K Doses), 2016-2021_x000D_
Table 45. By Country - Middle East & Africa Pertussis Vaccine Sales, (K Doses), 2022-2027_x000D_
Table 46. Sanofi Pasteur Corporate Summary_x000D_
Table 47. Sanofi Pasteur Pertussis Vaccine Product Offerings_x000D_
Table 48. Sanofi Pasteur Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)_x000D_
Table 49. GSK Corporate Summary_x000D_
Table 50. GSK Pertussis Vaccine Product Offerings_x000D_
Table 51. GSK Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)_x000D_
Table 52. Mitsubishi Tanabe Pharma Corporate Summary_x000D_
Table 53. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Offerings_x000D_
Table 54. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)_x000D_
Table 55. Wuhan Institute of Biological Products Corporate Summary_x000D_
Table 56. Wuhan Institute of Biological Products Pertussis Vaccine Product Offerings_x000D_
Table 57. Wuhan Institute of Biological Products Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)_x000D_
Table 58. Walvax Biotechnology Corporate Summary_x000D_
Table 59. Walvax Biotechnology Pertussis Vaccine Product Offerings_x000D_
Table 60. Walvax Biotechnology Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)_x000D_
Table 61. Minhai Biotechnology Corporate Summary_x000D_
Table 62. Minhai Biotechnology Pertussis Vaccine Product Offerings_x000D_
Table 63. Minhai Biotechnology Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)_x000D_
Table 64. Pertussis Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2019-2021 (K Doses)_x000D_
Table 65. Global Pertussis Vaccine Capacity Market Share of Key Manufacturers, 2019-2021_x000D_
Table 66. Global Pertussis Vaccine Production by Region, 2016-2021 (K Doses)_x000D_
Table 67. Global Pertussis Vaccine Production by Region, 2022-2027 (K Doses)_x000D_
Table 68. Pertussis Vaccine Market Opportunities & Trends in Global Market_x000D_
Table 69. Pertussis Vaccine Market Drivers in Global Market_x000D_
Table 70. Pertussis Vaccine Market Restraints in Global Market_x000D_
Table 71. Pertussis Vaccine Raw Materials_x000D_
Table 72. Pertussis Vaccine Raw Materials Suppliers in Global Market_x000D_
Table 73. Typical Pertussis Vaccine Downstream_x000D_
Table 74. Pertussis Vaccine Downstream Clients in Global Market_x000D_
Table 75. Pertussis Vaccine Distributors and Sales Agents in Global Market_x000D_
List of Figures_x000D_
Figure 1. Pertussis Vaccine Segment by Type_x000D_
Figure 2. Pertussis Vaccine Segment by Application_x000D_
Figure 3. Global Pertussis Vaccine Market Overview: 2020_x000D_
Figure 4. Key Caveats_x000D_
Figure 5. Global Pertussis Vaccine Market Size: 2021 VS 2027 (US$, Mn)_x000D_
Figure 6. Global Pertussis Vaccine Revenue, 2016-2027 (US$, Mn)_x000D_
Figure 7. Pertussis Vaccine Sales in Global Market: 2016-2027 (K Doses)_x000D_
Figure 8. The Top 3 and 5 Players Market Share by Pertussis Vaccine Revenue in 2020_x000D_
Figure 9. By Type - Global Pertussis Vaccine Sales Market Share, 2016-2027_x000D_
Figure 10. By Type - Global Pertussis Vaccine Revenue Market Share, 2016-2027_x000D_
Figure 11. By Type - Global Pertussis Vaccine Price (USD/Doses), 2016-2027_x000D_
Figure 12. By Application - Global Pertussis Vaccine Sales Market Share, 2016-2027_x000D_
Figure 13. By Application - Global Pertussis Vaccine Revenue Market Share, 2016-2027_x000D_
Figure 14. By Application - Global Pertussis Vaccine Price (USD/Doses), 2016-2027_x000D_
Figure 15. By Region - Global Pertussis Vaccine Sales Market Share, 2016-2027_x000D_
Figure 16. By Region - Global Pertussis Vaccine Revenue Market Share, 2016-2027_x000D_
Figure 17. By Country - North America Pertussis Vaccine Revenue Market Share, 2016-2027_x000D_
Figure 18. By Country - North America Pertussis Vaccine Sales Market Share, 2016-2027_x000D_
Figure 19. US Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 20. Canada Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 21. Mexico Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 22. By Country - Europe Pertussis Vaccine Revenue Market Share, 2016-2027_x000D_
Figure 23. By Country - Europe Pertussis Vaccine Sales Market Share, 2016-2027_x000D_
Figure 24. Germany Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 25. France Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 26. U.K. Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 27. Italy Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 28. Russia Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 29. Nordic Countries Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 30. Benelux Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 31. By Region - Asia Pertussis Vaccine Revenue Market Share, 2016-2027_x000D_
Figure 32. By Region - Asia Pertussis Vaccine Sales Market Share, 2016-2027_x000D_
Figure 33. China Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 34. Japan Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 35. South Korea Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 36. Southeast Asia Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 37. India Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 38. By Country - South America Pertussis Vaccine Revenue Market Share, 2016-2027_x000D_
Figure 39. By Country - South America Pertussis Vaccine Sales Market Share, 2016-2027_x000D_
Figure 40. Brazil Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 41. Argentina Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 42. By Country - Middle East & Africa Pertussis Vaccine Revenue Market Share, 2016-2027_x000D_
Figure 43. By Country - Middle East & Africa Pertussis Vaccine Sales Market Share, 2016-2027_x000D_
Figure 44. Turkey Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 45. Israel Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 46. Saudi Arabia Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 47. UAE Pertussis Vaccine Revenue, (US$, Mn), 2016-2027_x000D_
Figure 48. Global Pertussis Vaccine Production Capacity (K Doses), 2016-2027_x000D_
Figure 49. The Percentage of Production Pertussis Vaccine by Region, 2020 VS 2027_x000D_
Figure 50. Pertussis Vaccine Industry Value Chain_x000D_
Figure 51. Marketing Channels_x000D_

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us